TVARDI THERAPEUTICS INC (TVRD) Stock Analyst Ratings
USA - NASDAQ:TVRD - US1407553072 - Common Stock
4.03 USD
-0.08 (-1.95%)
4.03 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 77% to TVRD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.11. This target is 398.97% above the current price.
TVRD was analyzed by 14 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about TVRD.
In the last month the buy percentage fell by 8 points. So the trust of analysts is decreasing.
TVRD was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-14 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-10-13 | BTIG | Maintains | Buy -> Buy |
| 2025-10-13 | Barclays | Initiate | Overweight |
| 2025-07-14 | Raymond James | Initiate | Outperform |
| 2025-07-11 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-06-12 | Piper Sandler | Initiate | Overweight |
| 2025-05-21 | Oppenheimer | Initiate | Outperform |
| 2025-04-28 | Jones Trading | Initiate | Buy |
TVARDI THERAPEUTICS INC / TVRD FAQ
What is the price target for TVRD stock?
14 analysts have analysed TVRD and the average price target is 20.11 USD. This implies a price increase of 398.97% is expected in the next year compared to the current price of 4.03.
Can you provide the consensus rating for TVARDI THERAPEUTICS INC stock?
The consensus rating for TVARDI THERAPEUTICS INC (TVRD) is 77.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.